Sign In
Buy ARWR
$82.00
+0.180 (+0.220%)
At Close: Jun 22, 2026
Arrowhead Pharmaceuticals, Inc. (ARWR) Q2 2023 Earnings Call Transcript
08:42pm, Tuesday, 02'nd May 2023
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR ) Q2 2023 Earnings Conference Call May 2, 2023 4:30 PM ET Company Participants Vincent Anzalone - Vice President, Investor Relations Christopher Anzalone -
Why Shares of Arrowhead Pharmaceuticals Are Up Tuesday
11:20am, Tuesday, 25'th Apr 2023
Arrowhead has already announced it was receiving two milestone payments this month. The company has several late-stage therapies in trials.
Arrowhead Pharmaceuticals shares rise on positive interim trial results
11:07am, Tuesday, 25'th Apr 2023
Arrowhead Pharmaceuticals has released positive interim results from its Phase 1/2 study of its investigational therapeutic ARO-RAGE for inflammatory lung diseases such as asthma, sending its share pr
Arrowhead Pharmaceuticals to Webcast Fiscal 2023 Second Quarter Results
07:30am, Tuesday, 18'th Apr 2023
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on May 2, 2023, at 4:30 p.m. ET to discuss it
Is Arrowhead Pharmaceuticals a Buy Now?
05:21am, Sunday, 16'th Apr 2023
Arrowhead Pharmaceuticals recently received a rating upgrade from SVB Financial and a price target that implies a 44% gain up ahead. Arrowhead Pharmaceuticals is a precommercial-stage drugmaker with 1
Arrowhead Pharmaceuticals to Present at 43rd Annual Cowen Health Care Conference
07:30am, Friday, 03'rd Mar 2023
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the respiratory/infections panel discussion on March 8
Arrowhead Pharmaceuticals Requires Caution
02:19pm, Thursday, 23'rd Feb 2023
Arrowhead Pharmaceuticals, Inc. is a company with strong potential. However, it has yet to conclusively prove the worth of any part of its vast pipeline.
Here Are the 5 Best- and Worst-Performing Mid-Cap Stocks in January 2023
10:53pm, Monday, 13'th Feb 2023
For many investors, investing in mid-cap stocks is considered to be a safe portfolio diversification strategy because mid-caps can offer better returns than large-cap stocks and tend to be more stable
Arrowhead Pharmaceuticals, Inc. (ARWR) Q1 2023 Earnings Call Transcript
09:14pm, Monday, 06'th Feb 2023
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR ) Q1 2023 Earnings Conference Call February 6, 2023 4:30 PM ET Company Participants Vincent Anzalone - Vice President, Investor Relations Christopher Anzal
Why Omeros Are Trading Higher By 32%? Here Are Other Stocks Moving In Monday's Mid-Day Session
05:58pm, Monday, 06'th Feb 2023 Benzinga
Gainers
Secoo Holding Limited (NASDAQ: SECO) jumped 156% to $4.3600.
Arqit Quantum Inc. (NASDAQ: ARQQ) gained 41.5% to $3.54.
SoundHound AI, Inc. (NASDAQ: SOUN) shares climbed 39.7% to $3.9394. Shar
Energizer, Children's Place And Other Big Stocks Moving Lower On Monday
03:31pm, Monday, 06'th Feb 2023 Benzinga
U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Monday. Here are some big stocks recording losses in today’s session.
Canoo Inc. (NASDAQ: GOEV) dropped 13.8% to $1.0769 aft
Investing in Biotech ETFs
04:56pm, Friday, 20'th Jan 2023 The Motley Fool
Here are the five best biotech ETFs to invest in right now.
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
06:42pm, Monday, 09'th Jan 2023 Benzinga
Gainers
CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.
Apexigen, Inc. (NASDAQ: APGN) jumped 111% to
Arrowhead Pharmaceuticals to Present at 41st Annual J.P. Morgan Healthcare Conference
04:00pm, Wednesday, 21'st Dec 2022
PASADENA, Calif.--( BUSINESS WIRE )--Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to present on January 9, 2023, at 11:15 a.m. ET at the 41st Annual J.P. Morgan H
Arrowhead Pharmaceuticals: Good Work In Progress
12:29pm, Wednesday, 21'st Dec 2022
Arrowhead is a strong biotech with unique and powerful attributes. The company has seen its share of recent struggles, including in share price.
